CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-20 | Yocca Frank Chief Scientific Officer | Sale 10b5-1 | −6,845 | $1.09 | $7K | 26,175 |
| 2026-05-20 | Rodriguez Javier See Remarks | Sale 10b5-1 | −6,560 | $1.08 | $7K | 26,803 |
| 2026-05-20 | Steinhart Richard I Chief Financial Officer | Sale 10b5-1 | −6,845 | $1.09 | $7K | 26,300 |
| 2026-05-20 | Mehta Vimal CEO and President | Sale 10b5-1 | −19,419 | $1.09 | $21K | 69,598 |
| 2024-12-16 | O'Neill Vincent See Remarks | Sale 10b5-1 | −165 | $0.35 | $58 | 19,957 |
| 2024-12-16 | Mehta Vimal CEO and President | Sale 10b5-1 | −983 | $0.36 | $358 | 60,920 |
| 2024-12-16 | Mehta Vimal CEO and President | Sale 10b5-1 | −2,134 | $0.36 | $773 | 59,605 |
| 2024-12-16 | Steinhart Richard I Chief Financial Officer | Sale 10b5-1 | −205 | $0.36 | $74 | 21,157 |
| 2024-12-16 | Steinhart Richard I Chief Financial Officer | Sale 10b5-1 | −372 | $0.36 | $133 | 20,932 |
| 2024-12-16 | Rodriguez Javier See Remarks | Sale 10b5-1 | −210 | $0.36 | $75 | 24,643 |
| 2024-12-16 | Rodriguez Javier See Remarks | Sale 10b5-1 | −220 | $0.36 | $78 | 24,423 |
| 2024-12-16 | Yocca Frank Chief Scientific Officer | Sale 10b5-1 | −205 | $0.36 | $73 | 29,156 |
| 2024-12-16 | Yocca Frank Chief Scientific Officer | Sale 10b5-1 | −225 | $0.35 | $79 | 28,931 |
| 2024-10-03 | Wiley Matthew T. Chief Commercial Officer | Sale 10b5-1 | −6,272 | $0.55 | $3K | 19,011 |
| 2024-10-03 | Rodriguez Javier See Remarks | Sale 10b5-1 | −6,863 | $0.55 | $4K | 23,770 |
| 2024-10-03 | Yocca Frank Chief Scientific Officer | Sale 10b5-1 | −7,175 | $0.55 | $4K | 28,278 |
| 2024-10-03 | Steinhart Richard I Chief Financial Officer | Sale 10b5-1 | −7,175 | $0.55 | $4K | 20,279 |
| 2024-10-03 | O'Neill Vincent See Remarks | Sale 10b5-1 | −5,556 | $0.55 | $3K | 19,601 |
| 2024-09-16 | Yocca Frank Chief Scientific Officer | Sale 10b5-1 | −355 | $0.69 | $245 | 14,203 |
| 2024-09-16 | Mehta Vimal CEO and President | Sale 10b5-1 | −832 | $0.69 | $573 | 52,816 |
Page 1 of 6 · 106 trades